Amgen Launches $5B Stock Buyback, Senior Notes Offering

Law360, New York (November 7, 2011, 4:08 PM EST) -- Amgen Inc. will buy back up to $5 billion of its common stock through a modified Dutch auction tender offer and hold a public offering of its senior notes to help fund the tender offer, the biotech company said Monday.

The company said it will offer to buy the shares at $54 to $60 apiece and that the offer is expected to begin Tuesday and end at midnight Dec. 7. It is part of a $10 billion stock repurchase program announced Oct. 24.

“This tender offer...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.